 |
Market Research Report
Chronic spontaneous urticaria (CSU) - Epidemiology Forecast - 2030 |
||||||
| Published by | DelveInsight Business Research LLP | Product code | 952556 | ||||
| Published | Pre-Order | Content info | 100 Pages Delivery time: 2-10 business days |
||||
| Price |
|
||||||
| Chronic spontaneous urticaria (CSU) - Epidemiology Forecast - 2030 | ||
| Published: Pre-Order | Content info: 100 Pages |
|
DelveInsight's 'Chronic spontaneous urticaria (CSU) - Epidemiology Forecast - 2030' report delivers an in-depth understanding of the Chronic spontaneous urticaria (CSU), historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Chronic spontaneous urticaria (CSU) Disease Understanding
Chronic urticaria is a debilitating disease that is characterized by itching and hives with or without angioedema, lasting for more than 6 weeks. Chronic urticaria might be triggered due to stimuli such as stroking or scratching the skin, exercise, emotional upset (cholinergic urticaria), cold, heat, pressure, sunlight (solar urticaria), contact with water or various chemicals (contact urticaria), or vibration. Urticaria induced, thus, is known as chronic induced urticaria (CIndU). However, more commonly chronic urticaria is endogenous and independent of any external causes. This urticaria is known as chronic spontaneous urticaria (CSU).
However, there are still few unmet needs in the understanding of disease etiology in cases where autoimmunity is ruled out. Quality of life is severely impacted in CSU patients due to unpredictability of attacks, fatigue caused by treatment side effects, and cosmetic disfigurement. Patients with CSU often exhibit psychiatric comorbidities.
The Chronic spontaneous urticaria (CSU) epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Findings
The total prevalent cases of Chronic spontaneous urticaria (CSU) patients are increasing in 7MM during the study period, i.e. 2017-2030.
The disease epidemiology covered in the report provides historical as well as forecasted Chronic spontaneous urticaria (CSU) symptoms epidemiology segmented as the Total Prevalent cases of Chronic spontaneous urticaria (CSU), Gender-specific cases of Chronic spontaneous urticaria (CSU), Age-specific cases of Chronic spontaneous urticaria (CSU). The report includes the prevalent scenario of Chronic spontaneous urticaria (CSU) symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.
The epidemiology segment also provides the Chronic spontaneous urticaria (CSU) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The total prevalent cases of Chronic spontaneous urticaria (CSU) associated in 7MM countries was 1,169,632 in 2017.
KOL- Views
We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Key Questions Answered
The Chronic spontaneous urticaria (CSU) Epidemiology report will allow the user to -
Geographies Covered
Study Period: 2017-2030
Vietri et al. (2015) tried to estimate the effect of urticaria on the US population and prevalence using a retrospective, cross-sectional analysis of data taken from the US National Health and Wellness Survey (NHWS)-a large, cross-sectional survey designed to reflect health in the general population. The estimates used were close to Hellgran 1972 results, i.e., the point prevalence of 0.1%; however, the prevalence is thought to be increased over the last few decades.
Only a few studies have examined the prevalence of CSU in European countries. Lapi et al. (2015), used the Health Search IMS Health Longitudinal Patient Database (HSD), a longitudinal observational database established in 1998 by the Italian College of GPs, containing the electronic patient records from approximately 1000 GPs throughout Italy. Computer-based patient records collected by a selected group of 700 GPs, who met standard quality criteria regarding the levels of data entry, were included in the estimation of CSU prevalence in Italy.
Diagnostic Guidelines
Differential Diagnosis
Other treatments
The EAACI/GA²LEN/EDF/WAO guideline
